WEDNESDAY, June 17, 2015 -- Fluoroquinolone therapy for contacts of individuals with multidrug-resistant tuberculosis is associated with cost savings and reduced incidence of multidrug-resistant tuberculosis, according to a study published online April 27 in the American Journal of Respiratory and Critical Care Medicine.
